HeartWare International, Inc. (Nasdaq: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, ...
DUBLIN., The United States Food and Drug Administration (FDA) has classified Medtronic plc's recent voluntary urgent field action related to the HeartWare(TM) HVAD(TM) System unexpected power source ...
FRAMINGHAM, Mass. and SYDNEY, Jan. 9, 2012 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies ...
Medtronic's HeartWare HVAD pump system has been hit with a slew of recalls in recent months and the rate of device malfunction reports documented since it's been on the market in an FDA database ...
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, ...
Medtronic is recalling 23,372 HeartWare HVAD System batteries due to the risk that they could unexpectedly fail, the US Food and Drug Administration (FDA) says in an alert posted on its website.
HeartWare got FDA approval for its Ventricular Assist System--courtesy of HeartWare HeartWare ($HTWR) is gearing up to commercialize its Ventricular Assist System in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results